Increased proton pump inhibitor and NSAID exposure in irritable bowel syndrome: results from a case-control study

<p>Abstract</p> <p>Background</p> <p>Patients with irritable bowel syndrome (IBS) seen by a gastroenterologist often utilize medications that may alter intestinal homeostasis. The question arises whether exposure to these drugs is associated with the development of IBS...

Full description

Bibliographic Details
Main Authors: Keszthelyi Daniel, Dackus Gwen H, Masclee Gwen M, Kruimel Joanna W, Masclee Ad AM
Format: Article
Language:English
Published: BMC 2012-09-01
Series:BMC Gastroenterology
Subjects:
Online Access:http://www.biomedcentral.com/1471-230X/12/121
id doaj-a3dbddaffb4649a48a11688da48dce4c
record_format Article
spelling doaj-a3dbddaffb4649a48a11688da48dce4c2020-11-25T01:19:28ZengBMCBMC Gastroenterology1471-230X2012-09-0112112110.1186/1471-230X-12-121Increased proton pump inhibitor and NSAID exposure in irritable bowel syndrome: results from a case-control studyKeszthelyi DanielDackus Gwen HMasclee Gwen MKruimel Joanna WMasclee Ad AM<p>Abstract</p> <p>Background</p> <p>Patients with irritable bowel syndrome (IBS) seen by a gastroenterologist often utilize medications that may alter intestinal homeostasis. The question arises whether exposure to these drugs is associated with the development of IBS symptoms. Aim of this study was therefore to assess the use of PPIs and NSAIDs in patients with IBS versus controls.</p> <p>Methods</p> <p>Cases of IBS from the last 5 years were reviewed. All patients having had at least one prescription for a particular drug (PPIs, NSAIDs, SSRIs, diuretics, ACE inhibitors) in the 6 months prior to the time of initial symptom onset were considered exposed. The control group consisted of individuals randomly selected from the general population.</p> <p>Results</p> <p>287 cases of IBS were retrieved for analysis together with 287 age and sex-matched controls. Exposure to PPIs and NSAIDs was significantly higher in IBS patients, whereas no association between ACE inhibitor use and IBS was found. PPIs were not significantly associated when excluding patients with gastrointestinal reflux disease or functional dyspepsia. Exposure to SSRIs was also positively associated with IBS, but only when patients with psychiatric comorbidity were included in the analyses.</p> <p>Conclusions</p> <p>Medications that may alter intestinal homeostasis such as NSAIDs and PPIs were more frequently used in IBS patients compared to controls. This association might be relevant for everyday clinical practice, but it is remains to be elucidated whether this association is of etiological nature.</p> http://www.biomedcentral.com/1471-230X/12/121Irritable bowel syndromeProton pump inhibitorsNSAIDsSmall intestinal bacterial overgrowthIntestinal permeability
collection DOAJ
language English
format Article
sources DOAJ
author Keszthelyi Daniel
Dackus Gwen H
Masclee Gwen M
Kruimel Joanna W
Masclee Ad AM
spellingShingle Keszthelyi Daniel
Dackus Gwen H
Masclee Gwen M
Kruimel Joanna W
Masclee Ad AM
Increased proton pump inhibitor and NSAID exposure in irritable bowel syndrome: results from a case-control study
BMC Gastroenterology
Irritable bowel syndrome
Proton pump inhibitors
NSAIDs
Small intestinal bacterial overgrowth
Intestinal permeability
author_facet Keszthelyi Daniel
Dackus Gwen H
Masclee Gwen M
Kruimel Joanna W
Masclee Ad AM
author_sort Keszthelyi Daniel
title Increased proton pump inhibitor and NSAID exposure in irritable bowel syndrome: results from a case-control study
title_short Increased proton pump inhibitor and NSAID exposure in irritable bowel syndrome: results from a case-control study
title_full Increased proton pump inhibitor and NSAID exposure in irritable bowel syndrome: results from a case-control study
title_fullStr Increased proton pump inhibitor and NSAID exposure in irritable bowel syndrome: results from a case-control study
title_full_unstemmed Increased proton pump inhibitor and NSAID exposure in irritable bowel syndrome: results from a case-control study
title_sort increased proton pump inhibitor and nsaid exposure in irritable bowel syndrome: results from a case-control study
publisher BMC
series BMC Gastroenterology
issn 1471-230X
publishDate 2012-09-01
description <p>Abstract</p> <p>Background</p> <p>Patients with irritable bowel syndrome (IBS) seen by a gastroenterologist often utilize medications that may alter intestinal homeostasis. The question arises whether exposure to these drugs is associated with the development of IBS symptoms. Aim of this study was therefore to assess the use of PPIs and NSAIDs in patients with IBS versus controls.</p> <p>Methods</p> <p>Cases of IBS from the last 5 years were reviewed. All patients having had at least one prescription for a particular drug (PPIs, NSAIDs, SSRIs, diuretics, ACE inhibitors) in the 6 months prior to the time of initial symptom onset were considered exposed. The control group consisted of individuals randomly selected from the general population.</p> <p>Results</p> <p>287 cases of IBS were retrieved for analysis together with 287 age and sex-matched controls. Exposure to PPIs and NSAIDs was significantly higher in IBS patients, whereas no association between ACE inhibitor use and IBS was found. PPIs were not significantly associated when excluding patients with gastrointestinal reflux disease or functional dyspepsia. Exposure to SSRIs was also positively associated with IBS, but only when patients with psychiatric comorbidity were included in the analyses.</p> <p>Conclusions</p> <p>Medications that may alter intestinal homeostasis such as NSAIDs and PPIs were more frequently used in IBS patients compared to controls. This association might be relevant for everyday clinical practice, but it is remains to be elucidated whether this association is of etiological nature.</p>
topic Irritable bowel syndrome
Proton pump inhibitors
NSAIDs
Small intestinal bacterial overgrowth
Intestinal permeability
url http://www.biomedcentral.com/1471-230X/12/121
work_keys_str_mv AT keszthelyidaniel increasedprotonpumpinhibitorandnsaidexposureinirritablebowelsyndromeresultsfromacasecontrolstudy
AT dackusgwenh increasedprotonpumpinhibitorandnsaidexposureinirritablebowelsyndromeresultsfromacasecontrolstudy
AT mascleegwenm increasedprotonpumpinhibitorandnsaidexposureinirritablebowelsyndromeresultsfromacasecontrolstudy
AT kruimeljoannaw increasedprotonpumpinhibitorandnsaidexposureinirritablebowelsyndromeresultsfromacasecontrolstudy
AT mascleeadam increasedprotonpumpinhibitorandnsaidexposureinirritablebowelsyndromeresultsfromacasecontrolstudy
_version_ 1725138038362734592